Poxvirus vector encoding prostate specific antigens for treatment of prostate cancer

Details for Australian Patent Application No. 2004267117 (hide)

Owner Virax Development Pty Ltd

Inventors Howley, Paul Michael; Brown, Michael Paul

Agent Davies Collison Cave

Pub. Number AU-B-2004267117

PCT Pub. Number WO2005/019464

Priority 2003904496 21.08.03 AU

Filing date 20 August 2004

Wipo publication date 3 March 2005

Acceptance publication date 20 January 2011

International Classifications

C12N 15/863 (2006.01) Mutation or genetic engineering - Poxviral vectors, e.g. vaccinia virus

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 9/16 (2006.01) Enzymes, e.g. ligases (6.) - acting on ester bonds (3.1)

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

Event Publications

6 April 2006 PCT application entered the National Phase

  PCT publication WO2005/019464 Priority application(s): WO2005/019464

20 January 2011 Application Accepted

  Published as AU-B-2004267117

19 May 2011 Standard Patent Sealed

15 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004267118-Method and apparatus for condensing water from ambient air

2004267115-Methods for enhancing embryo viability